Logo image of GENT.OL

GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Price, Quote, News and Overview

OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK

46.8  -0.8 (-1.68%)

GENT.OL Quote, Performance and Key Statistics

GENTIAN DIAGNOSTICS ASA

OSL:GENT (3/7/2025, 7:00:00 PM)

46.8

-0.8 (-1.68%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High61
52 Week Low34.8
Market Cap721.66M
Shares15.42M
Float9.64M
Yearly DividendN/A
Dividend YieldN/A
PE16.31
Fwd PE25.78
Earnings (Next)N/A N/A
IPO12-14 2016-12-14


GENT.OL short term performance overview.The bars show the price performance of GENT.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

GENT.OL long term performance overview.The bars show the price performance of GENT.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 10 15 20

The current stock price of GENT.OL is 46.8 NOK. In the past month the price decreased by -3.7%. In the past year, price increased by 21.88%.

GENTIAN DIAGNOSTICS ASA / GENT Daily stock chart

GENT.OL Competitors/Peers

The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
EL.PA ESSILORLUXOTTICA 53.13 124.44B
ESL.DE ESSILORLUXOTTICA 53.09 124.35B
1EL.MI ESSILORLUXOTTICA 52.97 124.08B
CBHD.DE COLOPLAST-B 33.98 21.00B
GBT.PA GUERBET 10.23 341.28M
ALCJ.PA CROSSJECT N/A 91.07M
PTP.DE PENTIXAPHARM HOLDING AG N/A 89.03M
AFME.PA AFFLUENT MEDICAL SA N/A 55.09M
SVS.MI SVAS BIOSANA SPA 7.25 41.44M
IVN.MI IVISION TECH SPA N/A 16.85M

About GENT.OL

Company Profile

GENT logo image Gentian Diagnostics ASA is a medical diagnostics company, which engages in the design, development, and manufacture of biochemical reagents and materials for use in medical diagnostics and research. The company is headquartered in Moss, Ostfold and currently employs 58 full-time employees. The company went IPO on 2016-12-14. The firm develops and manufactures in vitro diagnostic (IVD) products for the detection and quantification of specific markers for use on a wide range of clinical chemistry analysers. The Company’s product portfolio comprises turbidimetric fecal calprotectin immunoassay, which is to be run on clinical chemistry analysers: The Gentian Calprotectin Immunoassay, Cystatin C, NT-proBNP - Pre-launch, SARS-CoV-2 Ab Pre-Launch, Canine CRP and Beckman Coulter Customers. The firm is based in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in Sweden, USA and China.

Company Info

GENTIAN DIAGNOSTICS ASA

Bjornasveien 5

Moss OSTFOLD NO

Employees: 58

Company Website: https://www.gentian.com/

Investor Relations: http://www.gentian.com/investor-relation

Phone: 4799339905

GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ

What is the stock price of GENTIAN DIAGNOSTICS ASA today?

The current stock price of GENT.OL is 46.8 NOK. The price decreased by -1.68% in the last trading session.


What is the ticker symbol for GENTIAN DIAGNOSTICS ASA stock?

The exchange symbol of GENTIAN DIAGNOSTICS ASA is GENT and it is listed on the Euronext Oslo exchange.


On which exchange is GENT.OL stock listed?

GENT.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for GENTIAN DIAGNOSTICS ASA stock?

7 analysts have analysed GENT.OL and the average price target is 68.34 NOK. This implies a price increase of 46.03% is expected in the next year compared to the current price of 46.8. Check the GENTIAN DIAGNOSTICS ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GENTIAN DIAGNOSTICS ASA worth?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a market capitalization of 721.66M NOK. This makes GENT.OL a Small Cap stock.


How many employees does GENTIAN DIAGNOSTICS ASA have?

GENTIAN DIAGNOSTICS ASA (GENT.OL) currently has 58 employees.


What are the support and resistance levels for GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a support level at 46.79 and a resistance level at 48.48. Check the full technical report for a detailed analysis of GENT.OL support and resistance levels.


Is GENTIAN DIAGNOSTICS ASA (GENT.OL) expected to grow?

The Revenue of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 33.11% in the next year. Check the estimates tab for more information on the GENT.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GENTIAN DIAGNOSTICS ASA (GENT.OL) stock pay dividends?

GENT.OL does not pay a dividend.


What is the Price/Earnings (PE) ratio of GENTIAN DIAGNOSTICS ASA (GENT.OL)?

The PE ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 16.31. This is based on the reported non-GAAP earnings per share of 2.87 and the current share price of 46.8 NOK. Check the full fundamental report for a full analysis of the valuation metrics for GENT.OL.


GENT.OL Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to GENT.OL. When comparing the yearly performance of all stocks, GENT.OL is one of the better performing stocks in the market, outperforming 79.29% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GENT.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL. GENT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GENT.OL Financial Highlights

Over the last trailing twelve months GENT.OL reported a non-GAAP Earnings per Share(EPS) of 2.87. The EPS increased by 520.09% compared to the year before.


Industry RankSector Rank
PM (TTM) 29.78%
ROA 19.72%
ROE 23.34%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%420.06%
Sales Q2Q%13.73%
EPS 1Y (TTM)520.09%
Revenue 1Y (TTM)12.52%

GENT.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to GENT.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 76.24% and a revenue growth 33.11% for GENT.OL


Ownership
Inst Owners30.99%
Ins Owners2.59%
Short Float %N/A
Short RatioN/A
Analysts
Analysts85.71
Price Target68.34 (46.03%)
EPS Next Y76.24%
Revenue Next Year33.11%